header logo image


Page 1,021«..1020..1,0201,0211,0221,023..1,0301,040..»

Kidneys from deceased diabetes patients may be organ donation source – CBS News

May 29th, 2017 2:44 am

People who received kidneys from non-living donors with diabetes were less likely to die than those who stayed on the wait-list.

istockphoto

Kidneys from deceased diabetic donors can save the lives of patients on the transplant wait-list, researchers say.

For the study, investigators compared U.S. data from more than 8,100 recipients of kidneys from deceased donors who'd had diabetes with data from people on the kidney transplant wait-list. The patients were followed for an average of nearly nine years.

People who received kidneys from diabetic donors were 9 percent less likely to die during that follow-up period than those who were still on the wait-list or were seeking a kidney from a non-diabetic donor, the study found.

The people who benefited most from diabetic donor kidneys were those who were most likely to die while on the wait-list, the researchers said.

Play Video

A growing number of families who have lost a relative to a drug overdose have found comfort by donating their loved one's organs. Kenneth Craig t...

But poor-quality kidneys from deceased diabetic donors did not improve survival chances, the findings showed.

And people under age 40 didn't benefit from diabetic donor kidneys, according to study author Dr. Jordana Cohen. She is an instructor at the University of Pennsylvania Perelman School of Medicine.

More than 100,000 people are on the U.S. kidney transplant wait-list. The study findings suggest that kidneys from deceased diabetic donors may help relieve the shortage of organs.

"As kidney disease has become increasingly common in the United States over the past few decades, the need for kidneys to be donated far exceeds the number of available kidneys," Cohen said in an American Society of Nephrology news release.

"As a result, poorer-quality kidneys are increasingly being used as a way to try to decrease transplant waiting times and thus decrease the number of people who die while waiting for a kidney transplant," she explained.

Play Video

Milwaukee judge Derek Mosley is back on the bench after receiving a life-saving kidney transplant. The organ donor was his friend and colleague, ...

The study was published online May 25 in theClinical Journal of the American Society of Nephrology.

The author of an accompanying editorial, Dr. Richard Formica Jr., said the study findings support the use of deceased-donor kidneys that would likely be discarded.

"However, as important as this finding is," Formica said, "it is necessary to view it in the context of the larger problem facing the nephrology community as it struggles to care for patients with end-stage renal disease."

Formica, a professor and director of transplant medicine at Yale University School of Medicine, said that only a fraction of money spent to treat end-stage kidney disease goes to kidney transplantation, even though it is better than dialysis and costs less.

"It is unfortunate that despite spending 17.4 percent of its [gross domestic product] on health care, the United States does not focus more of its resources on solving the problem through increasing access to kidney transplantation," he concluded.

2017 HealthDay. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Read more here:
Kidneys from deceased diabetes patients may be organ donation source - CBS News

Read More...

Puma Biotechnology (PBYI) Earns Media Sentiment Score of -0.01 – The Cerbat Gem

May 29th, 2017 2:41 am

FactsReporter
Puma Biotechnology (PBYI) Earns Media Sentiment Score of -0.01
The Cerbat Gem
Puma Biotechnology logo News coverage about Puma Biotechnology (NYSE:PBYI) has been trending somewhat negative recently, AlphaOne Sentiment reports. AlphaOne, a unit of Accern, ranks the sentiment of news coverage by analyzing more than ...
Brokerages Set Puma Biotechnology Inc (PBYI) Target Price at $68.42BBNS
Is Puma Biotechnology, Inc. (PBYI) a good buy?TopChronicle
Puma Biotechnology, Inc. (NYSE:PBYI) Stock Sees The Needle ...Concord Register
Transcript Daily -FactsReporter -Post Analyst -Zacks Investment Research
all 86 news articles »

Read the original:
Puma Biotechnology (PBYI) Earns Media Sentiment Score of -0.01 - The Cerbat Gem

Read More...

Link between obesity and arthritis – Ten Eyewitness News

May 29th, 2017 2:41 am

With Arthritis Awareness Week kicking off on Sunday, Medibank Better Health Index have released new data which outlines the concerning rise of osteoarthritis, and links between the condition and obesity.

Over the last nine years, the number of Australians living with osteoarthritis has increased from 6.2 to 8.5 per cent, which is equal to more than half a million additional cases.

The findings show the incidence of the condition has grown in line with the national trend towards obesity -- with 28.4 per cent of Australians falling into the obese Body Mass Index (BMI) category, compared to just 25.2 per cent in 2007.

Its an alarming trend given the already astute issues surrounding obesity in the country, and how much it is costing our healthcare system.

Medibank Chief Medical Officer Dr Linda Swan said the data should come as a wake-up call to Aussies.

Its concerning to see that the incidence of osteoarthritis is continuing to climb year-on-year, with almost one in ten Aussies now living with the condition.

We know osteoarthritis can be exacerbated by being overweight or obese, so its essential that we continue to encourage healthy eating habits and regular exercise as these can help both prevent and improve osteoarthritis symptoms.

While generally any type of activity is good, people's health risks can vary, so consulting your GP about the type of exercise that's right for you is always a wise step, Dr Swan said.

In South Australia alone, there are 124,000 patients living with osteoarthritis, 33,000 more than in 2007.

These findings support the need for ongoing research into osteoarthritis -- which the Medibank Better Health Foundation is committed to. Through this research, we aim to help those affected by musculoskeletal conditions improve their quality of life, and better understand, prevent and manage the condition, Dr Swan said.

In releasing the data, Medibank also provided some tips for preventing and managing osteoarthritis.

Keep Moving, safely: Exercise is vital in both managing the condition, and preventing it, as regular exercise helps to strengthen muscles and joints. There is a warning, however, not to overdo it. Too much exercise can cause injury and put an unnecessary stain on joints.

Follow a healthy diet: With obesity one of the leading causes of osteoarthritis, its extremely important to maintain a healthy, well0-balanced diet to maintain a healthy weight.

Opt for supportive footwear: Medibank writes thats having the right show means having the required support to carry your body. They recommend speaking to a podiatrist about choosing the appropriate footwear.

Continue reading here:
Link between obesity and arthritis - Ten Eyewitness News

Read More...

Promising Results for Drug for Psoriatic Arthritis – WebMD

May 29th, 2017 2:41 am

By Randy Dotinga

HealthDay Reporter

FRIDAY, May 26, 2017 (HealthDay News) -- A new drug might help ease the pain and disability of a form of arthritis often linked to psoriasis.

According to Stanford University researchers, psoriatic arthritis is an inflammatory joint disorder tied to an out-of-control immune response. The disease affects about one in every 200 people and is often accompanied by the autoimmune skin disorder psoriasis.

Psoriatic arthritis typically arises after the age of 30 and can bring stiffness, pain and swelling of the joints, leading to real disability if treatments don't help.

The new study focused on more than 300 adult patients across 10 countries. These patients were no longer seeing an effect from standard biologic drugs or had never experienced a benefit in the first place.

That's not uncommon.

"Only about half of psoriatic arthritis patients who are given TNF inhibitors get better," study lead author Dr. Mark Genovese said in a Stanford news release.

So, his team tried out a newer drug called Taltz (ixekizumab), already approved to fight psoriasis. The study was funded by the drug's maker, Eli Lilly & Co.

Patients were randomly assigned to receive injections of either Taltz or an inactive placebo. Over 6 months, about one-third got Taltz injections every two weeks, another third received the placebo every two weeks, while the remaining third received alternate injections of Taltz and the placebo.

More than half (53 percent) of those treated with the drug experienced at least a 20 percent reduction in the number of tender and swollen joints, compared to about 20 percent of those receiving the placebo, said Genovese. He's a professor of immunology and rheumatology at Stanford University Medical Center.

One expert in psoriatic arthritis was encouraged by the findings.

Taltz "is another new option for patients with psoriatic arthritis," said Dr. Waseem Mir, a rheumatologist at Lenox Hill Hospital in New York City. "The data shown in this article supports that certain patients who do not do well with other biologics that are in the market for psoriatic arthritis will now have another option for treatment of their painful disease," he said.

One potential side effect of these immune-focused drugs is a heightened vulnerability to infectious disease. However, Genovese said there was little difference in this regard between people taking Taltz and those on a placebo.

The study was published online May 24 in The Lancet.

WebMD News from HealthDay

SOURCES: Waseem Mir, M.D., rheumatologist, Lenox Hill Hospital, New York City; Stanford University School of Medicine, news release, May 24, 2017

Read more from the original source:
Promising Results for Drug for Psoriatic Arthritis - WebMD

Read More...

Cheyenne Mountain Zoo makes medical history with ‘giraffe sneakers,’ stem cell treatments – Colorado Springs Gazette

May 29th, 2017 2:40 am

Twiga, a 14-year-old female giraffe with advanced arthritis and osteoporosis in her feet, was fitted with custom shoes. (Photo courtesy of the Cheyenne Mountain Zoo.)

Cheyenne Mountain Zoo appears to have made medical history with its innovative giraffe treatments.

Mahali, a 14-year-old male giraffe who suffered from chronic lameness, is believed to be the first in the world to be injected with stem cells grown from giraffe blood, according to a news release from the zoo.

Stem cell therapy was chosen in the treatments led by Dr. Liza Dadone, the zoo's head veterinarian, because it has proven to repair damaged tissue. Staff at Colorado State University's James L. Voss Veterinary Teaching Hospital in Fort Collins helped with the treatment.

Nearly a month after the procedure, when Mahali was injected with about 100 million stem cells, thermographic images of the giraffe's front legs show "a considerable decline" in inflammation in his front left leg, the leg that had been giving him trouble, the zoo said.

"This is meaningful to us not only because it is the first time a giraffe has been treated with stem cells, but especially because it is bringing Mahali some arthritis relief and could help other giraffes in the near future," Dadone said in a written statement.

Dadone said it's not clear whether the successful results are due only to the stem cell treatment or a combination of treatments.

"Prior to the procedure, he was favoring his left front leg and would lift that foot off the ground almost once per minute," she said in the statement. "During the immobilization, we did multiple treatments that included hoof trims, stem cell therapy and other medications. "Since then, Mahali is no longer constantly lifting his left front leg off the ground and has resumed cooperating for hoof care. A few weeks ago, he returned to life with his herd, including yard access. On the thermogram, the marked inflammation up the leg has mostly resolved."

Twiga, a 14-year-old female giraffe with advanced arthritis and osteoporosis in her feet, was fitted with custom shoes with the help of farriers Steve Foxworth and Chris Niclas of the Equine Lameness Prevention Organization.

"We've had Twiga on medicine to help reverse her osteoporosis, but we wanted to do more to protect her feet. So with the help of the farriers, we gave her 'giraffe sneakers' to help give her some extra cushion," Dadone said in a written statement.

The giraffe's behavior was immediately changed - "Twiga instantly shifted her weight off of her right foot, indicating she was comfortable and her pain had considerably lessened" - but she will likely wear the shoes for about six more weeks, the zoo said.

Giraffes' size can make them more susceptible to issues like arthritis and osteoporosis. "Like all animals, these issues are exacerbated as they age," according to the zoo news release.

The zoo has a herd of 17 giraffes, including a newborn in April. The calf, a girl, was the 199th to be born in the 63-year history of the zoo's breeding program.

Giraffes' status was recently changed from "least concern" to "vulnerable" by the International Union for Conservation of Nature because the population in the wild has decreased by 40 percent in the last 30 years, the zoo said.

-

Contact Ellie Mulder: 636-0198

Twitter: @lemarie

Read the original post:
Cheyenne Mountain Zoo makes medical history with 'giraffe sneakers,' stem cell treatments - Colorado Springs Gazette

Read More...

Home / News / Ottawa Hospital Stem Cell Discovery ‘A… – www.ottawacommunitynews.com/

May 27th, 2017 10:43 pm

http://www.ottawacommunitynews.com/
Home / News / Ottawa Hospital Stem Cell Discovery 'A...
http://www.ottawacommunitynews.com/
A new stem cell treatment is in development at the hospital, which has the potential to heal the damaged lungs of premature babies, like Olivia. - Erin McCracken/ ... The research team originally thought these would replace the dead lung cells. But ...

Continued here:
Home / News / Ottawa Hospital Stem Cell Discovery 'A... - http://www.ottawacommunitynews.com/

Read More...

Baywatch’s Cultural Blindness – National Review

May 27th, 2017 10:42 pm

The new Baywatch movie, a reboot of the Nineties beach-set crime-and-melodrama TV series, continues Hollywoods unoriginal marketing. It holds momentary interest for the way it adapts television culture (free, meaningless distraction) for a new era.

On the big screen, Baywatch might seem a variation on its cathode-ray source simply because it stars Dwayne The Rock Johnson, Hollywoods leading exponent of biracial diversity, and Zac Efron, Hollywoods newest male pin-up. Respectively, they play lifeguards Mitch and Matt not entirely interchangeable but alliterative nonentities who bring little distinction to the basic formula. The combination of over-the-top action-movie stunts and crass humor is shameless, both below-the-belt and beneath most folks IQs.

Hollywood movies have become television at just the point when media shills are spreading the fake news that were experiencing a new golden age of TV. These shills dont call it a renaissance, because that word might intimidate victims of our failed education system and even cynics realize that nothing gets reborn in Hollywood, that recycling is not the same as being given new life.

Yet the level of audacity in the Baywatch movie, directed by Seth Gordon with the same insipidness he brought to Identity Thief and Horrible Bosses, is greater than in the cornball TV series. And Johnsons and Efrons exaggerated beefcake and lame ethnic contrasts add to the overkill. Only a child mired in TV cultures hard sell would find any of this unique. Such unenlightened appreciation would be a sign of the cultural catastrophe in which old television shows are granted the same interest that Hollywood used to give to classic drama and literature. This pop-culture emergency is more urgent that the films plot, in which the team of lifeguards oppose a drug dealer (Priyanka Chopra), an idea rehashed from last months movie version of the TV series CHiPs.

What Millennial children and hack reviewers dont admit is that this shift of values, the inevitable triumph of assaults on the cultural canon (the old low- vs. high-culture debate), defines a state of widespread desperation: Hollywood is desperate to make money, without the risk of creativity, and audiences are eager to be distracted from their daily, dangerous, antagonistic, collapsing reality. Baywatch, while offering incessant juvenile sitcom bromides about competition (competence) and sex (relationships), disguises those concerns while making them trite. It plays the audience cheap.

The pandering involved in making a film version of a TV series cravenly calculates the publics taste for T & A and chase scenes. This blatancy is regressive. A Baywatch movie works backward from the Sixties beach-movie series Gidget that then became a TV show. The display of muscle strain during a Rock vs. Zac beach competition is worse than obvious; its not as light-hearted as the beach competition in Dirty Grandpa, and it misses the reality-show tension of Steve Austins Broken Skull Challenge.

If Baywatch were better than junk, it might deserve a semiotic analysis of its leisure-place setting, diversity casting, and smutty premise that devolves into law-and-order banality. But we are at a stage of escapist desperation that a critic has to wonder whether that desperation is worth exposing. Neither Johnsons Mitch nor Efrons Matt shows the depth that might make audiences relate to them as people. (That was the surprise of Johnsons characterization in Michael Bays superb Pain & Gain, in which he played muscle-head psychosis as a symptom of greed and insecurity a modern condition made revelatory and funny.)

It wont do to dismiss Baywatch as the start of the summer inanity (movie inanity is a year-long problem). But consider the beach-movie idea to which Baywatch is historically inferior. Alexander Mackendricks sex farce Dont Make Waves (1967) depicted the edifice of American morality as nearing collapse. In Daniel Petries The Lifeguard (1977), a rare character study of male concupiscence, the casually macho Sam Elliott faces moral obligation. And, best of all, recall Eric Rohmers serene, erotic farce Pauline at the Beach (1983). All dealt with the sexual mores of their times, but TV culture never gets that deep and apparently has not inspired erotic reflection even in a reboot.

There are going to be more and more movies like this, many from TV series, most from comic books. But the lesson that must be learned is that escapism especially when its TV-based amounts to cultural idiocy. Despite its sun-bright carousing, cuss words, and explosions, Baywatch merely takes its cue from TV manipulation of the shut-ins and the adolescents sexual prurience. These hedonistic beach-bunny hijinks are Hollywoods own winking equivalent of the 72-virgins promise that inveigles terrorists.

Armond White is the author of New Position: The Prince Chronicles.

Continued here:
Baywatch's Cultural Blindness - National Review

Read More...

Promising Results for Drug to Fight Arthritis Linked to Psoriasis … – Arizona Daily Star

May 27th, 2017 10:41 pm

FRIDAY, May 26, 2017 (HealthDay News) -- A new drug might help ease the pain and disability of a form of arthritis often linked to psoriasis.

According to Stanford University researchers, psoriatic arthritis is an inflammatory joint disorder tied to an out-of-control immune response. The disease affects about one in every 200 people and is often accompanied by the autoimmune skin disorder psoriasis.

Psoriatic arthritis typically arises after the age of 30 and can bring stiffness, pain and swelling of the joints, leading to real disability if treatments don't help.

The new study focused on more than 300 adult patients across 10 countries. These patients were no longer seeing an effect from standard biologic drugs or had never experienced a benefit in the first place.

"Only about half of psoriatic arthritis patients who are given TNF inhibitors get better," study lead author Dr. Mark Genovese said in a Stanford news release.

So, his team tried out a newer drug called Taltz (ixekizumab), already approved to fight psoriasis. The study was funded by the drug's maker, Eli Lilly & Co.

Patients were randomly assigned to receive injections of either Taltz or an inactive placebo. Over 6 months, about one-third got Taltz injections every two weeks, another third received the placebo every two weeks, while the remaining third received alternate injections of Taltz and the placebo.

More than half (53 percent) of those treated with the drug experienced at least a 20 percent reduction in the number of tender and swollen joints, compared to about 20 percent of those receiving the placebo, said Genovese. He's a professor of immunology and rheumatology at Stanford University Medical Center.

One expert in psoriatic arthritis was encouraged by the findings.

Taltz "is another new option for patients with psoriatic arthritis," said Dr. Waseem Mir, a rheumatologist at Lenox Hill Hospital in New York City. "The data shown in this article supports that certain patients who do not do well with other biologics that are in the market for psoriatic arthritis will now have another option for treatment of their painful disease," he said.

One potential side effect of these immune-focused drugs is a heightened vulnerability to infectious disease. However, Genovese said there was little difference in this regard between people taking Taltz and those on a placebo.

The study was published online May 24 in The Lancet.

Here is the original post:
Promising Results for Drug to Fight Arthritis Linked to Psoriasis ... - Arizona Daily Star

Read More...

Arthritis medication naprelan – Naproxen for arthritis dosage – Naproxen or ibuprofen for rheumatoid arthritis – Utah Political Capitol

May 27th, 2017 10:41 pm

Welcome to the UPC Show with Curtis Haring, Alex Cragun, and Dylan McDonnell. On the show today we talk about the growing fight between the legislature and the governor around a special session to potentially replace Jason Chaffetz, Speaker of

Read more

Welcome to the UPC Show with Curtis Haring and Alex Cragun with special guest Bob Kubichek. On the show today we talk about new signage requirements in bars versus restaurants, Donald Trump looks into Bears Ears, Jim Matheson has gotten

Read more

Welcome to the UPC Show with Curtis Haring and Alex Cragun. On the show today we talkabout Jason Chaffetzs surprise announcement, the rest of the Utah delegation is having poll trouble, Trumps budget has a real impact on Utah, and

Read more

Welcome to the UPC Show with Curtis Haring, Dylan McDonnell,and Alex Cragun. On the show today we talk about some proposed changes to an initiative to fund education, Chris Stewarthas a Democratic challenger, and Orrin Hatch might be on the

Read more

Welcome to the UPC Show with Curtis Haring, Dylan McDonnell,and Alex Cragun. In the first half: UTAs woes and Rocky Mountain Power assumes that EPA regulations will be rolled back. In the second half: An audit shows that sex-offender treatment

Read more

A general expressionof concern about the recent hospitalization of Senator Ralph Okerlund (RepublicanMonroe) was made at the Central Utah Leadership Summit, an annual gathering of elected officials and economic development experts in rural Utah. Public announcementsby both Byron Woodland, Board

Read more

Welcome to the UPC Show with Curtis Haring, Dylan McDonnell,and Alex Cragun. In the first half: Orrin Hatch says he is willing to step asideif someone like Mitt Romney steps in and people booingRepresentative Stewart at a recent town hall

Read more

Welcome to the UPC Show with Curtis Haring, Dylan McDonnell,and Alex Cragun. This week we round out the three part legislative extravaganza by talking about Business, specifically:HB 40 Check Cashing and Deferred Deposit Lending Amendments Brad Daw (Republican

Read more

View other reviews in this series: Agriculture, Air Quality, and Alcohol Business, Campaign Finance, Crime and the Courts Drugs HB 50 Opioid Prescribing Regulations from Representative Ray Ward (Republican Bountiful) If you have been paying attention to public

Read more

More here:
Arthritis medication naprelan - Naproxen for arthritis dosage - Naproxen or ibuprofen for rheumatoid arthritis - Utah Political Capitol

Read More...

First Indy 500 Driver with Diabetes Talks About Racing, Life with His Disease – Healthline

May 26th, 2017 2:45 pm

It all started with a skin rash.

Ten years ago, race car driver Charlie Kimball went to his doctor to check out that small rash on his arm.

In the course of their conversation, the physician learned that Kimball had also been unusually thirsty in recent days.

When he weighed Kimball, the doctor discovered his patient had lost 25 pounds in five days.

He immediately suggested Kimball be tested for diabetes.

Kimball admits he was pretty clueless about the disease. He even asked his doctor if he could prescribe antibiotics for it.

I didnt know what it was or what it involved, Kimball told Healthline.

He soon found out when he was officially diagnosed at age 22 with type 1 diabetes.

Since that time, Kimball has become educated about diabetes.

He has also adjusted his life, both at home and behind the wheel of his race car.

A few years after his diagnosis, Kimball became the first person with diabetes to be allowed to drive in the Indianapolis 500.

On Sunday, he will compete in his seventh Indy 500 race.

As he circles that famed track the required 200 laps, Kimball will have a water bottle and a container of orange juice by his side.

Hell also be watching his blood glucose level on his dashboard.

Read more: Athletes with diabetes to follow on social media

Kimball concedes his diabetes diagnosis was a bit of a shock.

At age 22 you feel 10 feet tall and bulletproof, he said.

Kimball immediately had to start changing his daily routine.

He now takes insulin four times per day. One dose is a long-lasting insulin he takes in the morning. The other three are fast-acting insulin he takes after each meal.

Kimball also watches his diet much more closely.

He has learned that the carbohydrates in pizza, for example, take longer to enter the blood stream than most foods. He learned that corn has carbohydrates, too.

Kimball was initially worried about whether hed be able to continue race car driving.

I was concerned about getting back in my race car, he recalled. The race car is the only place I feel really alive.

That involved more than just driving.

Race car drivers are athletes.

They are handling vehicles without power steering that are traveling around 200 miles an hour.

The stress keeps their heart rate high throughout an entire three-hour race. They can lose seven pounds of water weight due to the heat of the car. And they can burn more than 1,100 calories in a single race.

Im always concerned about the safety element and the performance element, he said.

Kimball quickly learned, however, that his new dietary routine was actually enhancing his skills.

It helps me be a better athlete, he commented.

During his races, Kimball wears special sensors on his skin that monitor his body functions.

On his dashboard, he can monitor his blood glucose level and other health-related data along with his cars speed and how many laps he has completed.

Kimball said it isnt a coincidence hes the first Indy 500 driver with diabetes.

Until recent years, there wasnt the technology to provide enough support and assistance to a driver with this particular condition.

In addition, Kimball said, most people with type 1 diabetes are diagnosed when they are children.

At that stage, most kids with the disease dont envision becoming a race car driver.

Kimball, on the other hand, was already doing it.

I wasnt going to let diabetes get in the way of my lifes dream, he said.

Read more: NASCAR driver getting the word out on colorectal cancer

Kimball hopes his drive to continue his race car career will inspire children and others with diabetes.

He said he wants youngsters to feel like they still can do whatever they want, whether its being an athlete, a rock climber, or a chief executive officer.

I want them to be able to chase their dreams, he said.

Kimball is also participating in a program at Michigan State University to study exercise physiology and race car driving.

David Ferguson, PhD, an assistant professor of kinesiology, oversees the program. Ferguson has been doing this kind of research for 12 years.

When Kimball came along, Ferguson saw an opportunity to hone his research even more.

Charlie is a good model for us to work with, Ferguson told Healthline.

One of the more interesting experiments the researchers have worked on is how driving on an oval track seemed to be a more difficult task for Kimball than driving on a more winding, surface street race course.

To discover what was happening, the researchers outfitted Kimball with a clear plastic box that encased his body from the waist down. The case was accompanied by some wooden blocks, cushions, and a bicycle seat.

By taking readings with the box, the researchers discovered that the blood in Kimballs lower legs was pooling more on oval courses because there are stronger g-forces.

With that knowledge, they set up a training schedule that exposed Kimball to that type of g-force to help him condition himself for it.

Ferguson said they hope to use what they learn from their experiments with Kimball to help the general population with diabetes management.

For Kimball, all of this helps him when hes on the race track.

The past two years, he has finished third and fifth in the Indy 500.

Hes hoping for an even better finish on Sunday.

If you want to keep track, Kimball will be in the car with the number 83 and the Novo Nordisk sponsor decals.

Read more: World Cup soccer stars next goal is to conquer lupus

Read more here:
First Indy 500 Driver with Diabetes Talks About Racing, Life with His Disease - Healthline

Read More...

Free diabetes testing in Torrevieja and Murcia – RTN Newspaper

May 26th, 2017 2:45 pm

THE QUIRONSALUDhospitals in Torreviejia and Murcia will be conducting free testing for diabetes next Monday May 29, between the times of 09.00h and 11.00h to coincide with World Nutrition Day, which falls on Sunday.

Obesity, physical inactivity and poor nutrition increase the number of obese and diabetic people every year. People are unaware of the fatal consequences of this chronic disease as diabetes is a condition that is triggered when the body does not produce enough insulin or does not use it effectively.

There are several types: Type 1 diabetes is the most common childhood disease. The pancreas does not produce insulin, so an excess of blood sugar is created, which makes it necessary to provide the body with injected insulin.

According to Oscar Boullosa, coordinator of the Diabetes Unit of the Hospital Quirnsalud Torrevieja, type 2 diabetes is the most common, 90% of diabetic patients suffer with this type, they are generally over 40 years old, and their body does not produce enough insulin to take advantage of glucose or are resistant to it. These individuals require a balanced diet and exercise.

This multidisciplinary unit monitors all reviews of diabetic patients annually ensuring disease control.

In Spain, about 26,000 children under the age of 15 suffer from type 1 diabetes, 13% of all diabetics. More than 5,500,000 people are estimated to suffer with type 2, of whom 43% are undiagnosed, that is, they do not know they have the disease. Figures that are increasing and indicate that in 20 years could be increased by up to 55%. One in six adults are obese and one in four children are overweight, an excellent breeding ground for the illness. Diabetes can be cured and the data is clear: more than 70% of obese patients undergoing bariatric or metabolic surgery cease to become diabetic.

The effectiveness is immediate in patients with type 2 diabetes, who usually stop using insulin and medication in the weeks following the intervention, explains Dr. Juan Lujn, head of service and head of the Unit for Obesity and General Surgery and Digestive System of Hospital Quirnsalud Murcia.

Those interested in attending the Hospital Quirnsalud Murcia can request information by phone 968 011 197 or email prevencion.mur@quironsalud.es or through the web http://www.quironsalud.es/hospital-murcia

Those who wish to do so at the Hospital Quirnsalud Torrevieja can obtain all the information by phone 966 925 770 or by email prevencion.trv@quironsalud.es or through the web http://www.quironsalud.es/torrevieja/es

To perform the test it is necessary to be nil by mouth from the night before.

Visit link:
Free diabetes testing in Torrevieja and Murcia - RTN Newspaper

Read More...

Local youngster headed to DC to lobby for T1 diabetes research funding – The Bridgton News

May 26th, 2017 2:44 pm

Brady Chappell

By Wayne E. Rivet

Staff Writer

NAPLES He may be just nine years old, but Brady Chappell has an important message he plans to share with lawmakers.

The Naples boy is headed to Washington, D.C., this July, where he will lobby to increase funding for Type 1 Diabetes research.

Brady was selected to serve as one of two Maine delegates to the biennial JDRF Childrens Congress.

JDRF is the leading global organization funding Type 1 Diabetes (T1D) research.

Our strength lies in our exclusive focus and singular influence on the worldwide effort to end T1D, according to the JDRF website.

Just last weekend, Brady was honored to be invited by U.S. Senator Susan Collins to attend the annual JDRF Gala in Manchester, N.H., where the N.H. and Maine delegates were introduced to the attendees. Brady was able to meet both Sen. Collins and Sen. Shaheen (N.H.), who were in attendance to receive awards from JDRF for their work on behalf of the T1D community. Brady was even able to sit next to Sen. Collins at dinner.

Both senators are co-chairwomen of the Senate Diabetes caucus, which was also founded by Sen. Collins.

Brady was diagnosed with T1D at the age of six. Brady a very athletic, energetic and intelligent kid was diagnosed with T1D around Valentines Day of 2014. He had been recovering from a long bout with an illness when, thankfully, his grandmother noticed he was going to the bathroom a lot. He was also looking rather thin and was uncharacteristically lethargic. Just to be sure everything was okay, his parents Tait and Jeanette Chappell made an appointment with his doctor.

Needless to say, we were blown away when the doctor took his blood sugar and said, You need to take him to the hospital immediatelyhe has Type 1 Diabetes! What? Just like that? You dont need to do more tests? This wasnt something that was even on our radar as a possibility, the Chappells said. The doctors said that we were lucky and caught it relatively early before his blood sugar, at that point over 600, had gone even higher.

While it was a startling diagnosis, the Chappells were happy for Brady that he was being taken care of and was finally feeling better. Although a bit scared, Brady took the news in stride and was resolved to learn all he could about T1D.

The resilience of children is an amazing thing. Within two weeks, he was giving himself shots, taking his own blood sugar and counting carbs. He continues to amaze us! the couple said.

T1D can feel relentless at times, with all the finger sticks and sleepless nights, managing lows. Anything that can help alleviate that feeling is a tremendous thing. Brady now uses a Dexcom CGM and loves using the Omnipod insulin pump.Both of these devices have benefited from previous JDRF funding and help to make his daily diabetes care easier to manage.

But, the Chappells believed they could do better!

Three years ago, they were very happy to join the JDRF Walk to Cure Diabetes and help to raise money to find a cure. They were overwhelmed when Bradys Bunch raised over $20,000 in the first year. They were also very happy to sponsor a JDRF Kids Walk at Bradys school, which raised an additional $5,000.

The next Bradys Bunch fundraising effort is the JDRF One Walk 5K on Sunday, Sept. 17, starting at Thornton Academy in Saco. Check-in is at 10 a.m. with a start at 11 a.m. The goal is to raise $15,000. To make a donation to team Bradys Bunch, go to http://www.jdrf.org website, under events go to One Walk, a box allows you to enter your zip code for a walk near you, select the Saco walk and you will find teams signed up for the event, click Bradys Bunch, and make a donation.

When Brady grows up, he wants to be a professional baseball player or an engineer. He loves sports, especially baseball, football, basketball and skiing.

Although constantly tracking his blood sugar can be difficult, Brady says, Diabetes doesnt stop me from doing anything. I just always have to think about diabetesI was sad when my doctor told me that unless we found a cure, I would have diabetes for the rest of my life. That made me want to find a cure.

The JDRF 2017 Childrens Congress will take place on July 2426 in Washington, D.C. Every two years, more than 150 children living with Type 1 Diabetes (T1D) gather in Washington, D.C., to meet face-to-face with some of the top decision-makers in the U.S. government. The children, ages 4 to 17, represent all 50 states and the District of Columbia. The delegates in JDRFs Childrens Congress enjoy a once-in-a-lifetime opportunity to help members of Congress understand what life with T1D is like and why research to fund life-changing therapies until a cure can be found is so critical. They speak up on behalf of the millions of people living with T1D and the families and friends who love them.

The JDRF Childrens Congress T1D advocacy program was inspired by a boy from Massachusetts named Tommy Solo. One day, at age nine, he asked his mother, Why cant kids go to Washington and tell their representatives about what it is like to have Type 1 Diabetes and let them know that we want scientists to find a cure?

His mom and other JDRF volunteers agreed and, in 1999, the first-ever JDRF Childrens Congress took place in Washington, D.C.

Since then, ninesuccessful Childrens Congresses have been held, one every other year, and more than 1,000 kids with T1D have served as delegates. JDRF Childrens Congress has been essential to securing continued government funding of T1D research and to raise awareness of the daily burden of Americans living with this serious autoimmune disease.

Delegates form lifelong friendships, meet T1D role models, develop leadership skills, and leave Childrens Congress empowered to use their voices for the change that will improve their lives and the lives of all people affected by T1D.

Excerpt from:
Local youngster headed to DC to lobby for T1 diabetes research funding - The Bridgton News

Read More...

CADH to host health fair; mobilizes resources through diabetes & hypertension screening and counseling – The Maravi Post

May 26th, 2017 2:44 pm

Community members at Chinsapo township in Lilongwe going through diabates screening for funds mobilization

LILONGWE-(MaraviPost)-The Community against Diabetes & Hypertension (CADH) in Malawi, has intensified its resource mobilization through diabetes and hypertension screening, and counseling, ahead of the health fair, slated for July 29.

The screening and counseling exercise is targeting individuals, companies, and institutions of goodwill. This enabled CADH to collect monies or material in return of the services.

The health fair, which will be held in Lilongwe, will be the first of its kind focussing on all non-communicable diseases (NCDs). The health fair comes barely two months after CADH opened its counseling centre in the capital, with the central quest to upscale awareness campaigns on diabetes and hypertension.

The fair aims to increase health awareness to the public, by providing health screenings, demonstrations, and information.

Speaking in an interview with The Maravi Post a head of the health fair, CADHs Programs Manager, Thomas Psyata, said diabetes and hypertension diseases were claiming many lives silently, hence the need for the mass awareness campaign.

Psyata said that the health fair will be a platform to demonstrate the effect of community peer supporting groups in prevention and treatment of diseases.

He added that this is the reason the organization launched the resource mobilization campaign, to meet the cost of the fair. He said the fair would also motivate participants to champion self-care practices, and make positive health behavioral change.

Since we opened the counseling centre, there have been overwhelming responses from communities as far as Mzimba for our services. But our limited resources, especially human and mobility, have been our main constraints to reach more people.

With the health fair slated for July 29, this year, we hope to increase awareness on NCDs particularly diabetes, hypertension, cancer among others. This is the reason we are visiting individuals, companies, institutions with our services, and that in return, they give us money or any material to support, to help finance the health fair preparation, said Psyata.

Psyata therefore asked people to support the initiative for their own good, as it focuses on improving the health status of the nation.

Established in 2016, CADH, is serving local communities in awareness campaigns, prevention and treatment of diabetes and hypertension. CADH is operational in six districts Lilongwe, Balaka, Salima, Dedza, Rumphi and Mzimba.

According to the World Health Organization, diabetes results in high healthcare costs, loss of labour productivity, and decreased rates of economic growth.

Globally, healthcare expenditure for diabetes totaled US$465 billion in 2011, equivalent to 11% of total health spending.

Without an investment in making effective treatments for preventing diabetes complications will arise widely, and predictably rise to US$595 billion by 2030.

Continue reading here:
CADH to host health fair; mobilizes resources through diabetes & hypertension screening and counseling - The Maravi Post

Read More...

Geeks Vs Loneliness: face-blindness – Den of Geek UK

May 26th, 2017 2:42 pm

Welcome to Geeks Vs Loneliness, our spot on the site where we chat about things that may be affecting you, or people you know. This week, we're handing over to Shawm Kreitzman, who wants to talk about something we're betting many of you - us included - hadn't heard of before...

A few years ago, I stumbled across the trailer for Anomalisa on YouTube.

I had never heard of the film, but I watched the trailer with mild interest and thought it looked like a curious (if slightly melancholy) piece of stop-motion animation, nicely executed, but ultimately unremarkable. I let my mouse wander on to something else, and didnt give it another thought.

Until my girlfriend happened to see it, that is.

That was incredibly creepy, she said to me, after seeing the clip.

Creepy? I had thought the mood was a little on the glum side, the general tone rather drab. But creepy?

All the faces are exactly the same, she told me.

Apparently thats the whole point of the film. I hadnt actually noticed it.

From where I sit, you have a superpower. Congratulations. You may not have X-Ray vision, or Adamantium claws that spring out of your knuckles (and be honest, how useful would that really be at the office) but there is something that you do every day; something that is completely beyond my abilities. You can distinguish one face from another.

I happen to suffer from face-blindness (prosopagnosia, to its friends) which means I find it very, very difficult to tell faces apart.

Think for a moment about how many different faces you have seen in your life. Apart from your family and friends, there are the faces of your neighbours; there are the thousands of commuters you have passed on your way to work, and the total strangers you see in the supermarket. There were the faces of the other kids at your school, back in the day. And thats before we even start talking about the faces you see in the Media: politicians, actors, celebrities, lingerie models, football hooligans etc.

Somehow, those millions of faces all look different to you. I have absolutely no idea how you do it.

Never mind the faces in Anomalisa; all faces look alike to me. Jason Statham and Clark Gregg look alike to me, apart from the hair (dont tell the staff at Den Of Geek I said that). Show me a photo of the Beatles and I see four identical white kids with silly haircuts. With a gun to my head I couldnt tell you which one is which.

Im not blind; my vision is perfectly fine. I can read the bottom line of the eye-chart forwards and backwards without breaking a sweat. But if I should happen to bump in to my optician at the grocery store an hour later, I will have absolutely no idea who she is.

Most people, it seems, are hard-wired to distinguish the tiniest variations in facial features and perceive those variations as a unique individual without even realising they are doing it. I never got those wires. When I look at a human face, I see the eyes, nose and mouth right where theyre supposed to be. I can see that some people have brown eyes, some people have blue eyes and such like.

But to take all those features and use them to construct a unique person? That is completely beyond my ability.

Like many people with prosopagnosia, I spent most of my life with absolutely no idea I had it. Indeed, it wasnt until I was in my 30s that I even knew it could be a thing. Before that, I just assumed I simply wasnt paying enough attention. After all, everyone else seemed to recognise each other with ease. Why couldnt I do that?

There were plenty of socially awkward moments. I hated parties, or any situation where I would be expected to meet a large number of new people in a short time (I still do). When I worked in a shop, I was hopeless at recognising regular customers when they walked in (until they spoke to me, at which point I would recognise them at once. Im exceptionally good with voices.). If someone changed their look significantly (shaved their beard, lost a lot of weight, dyed their hair purple etc) they instantly became a stranger to me. And I was useless at spotting familiar actors in films.

Before I read about prosopagnosia, it had never occurred to me that others might be seeing faces differently. When I recognise people (and I do recognise people all the time) its usually by their hair; their voice; their body language. I just assumed that everyone else did the same thing, only much better.

The biggest problem with face-blindness is that most people have never heard of it. Tell someone youre colour-blind and they will understand immediately. Tell them youre dyslexic and they will nod, sympathetically. But prosopagnosia? Is that contagious? Do you take pills for it? (No, you dont, by the way. Theres no treatment per se.) And if you fail to recognise someone youre supposed know, they can become very offended very quickly. Even after I explain it (which I rarely bother to do) people are often sceptical.

So you really cant see my face? they ask.

Of course I can see your face; its right where you think it is. I just cant see what makes your face different from the countless other faces I have seen in my lifetime. (And my prosopagnosia is relatively mild. Some people are unable to recognise their own family, or even themselves in mirrors and photographs.)

Please dont be offended. Its nothing personal, but thats exactly the problem. For most people, The Face is the most personal thing there is (theres a reason they dont call it Voicebook).

The irony is that Im not troubled by any of this, although that wasnt always the case.

Before I knew what it was, I struggled with it quite a bit. I thought I must be doing something wrong; I thought I simply wasnt being observant enough. This is a story I have heard from many others with the same condition. Many of us are terrified of meeting people, of interacting with anyone, for fear of embarrassing ourselves or inadvertently causing offence. We simply dont realise that we truly see the world differently.

When you're different, you tend to experience things through a filter. If something happens and you react one way while everyone else reacts another way, your first response is generally to wonder why. If I wasnt reacting to things the way normal people do, then obviously we're seeing things differently. When I eventually realised I was face-blind, it didn't scare me or disturb me; it made perfect sense. I was literally seeing things differently.

Normal is my least-favourite word in the English language. Remember Malcolm McDowell's line from Star Trek: Generations? Normal is what everyone else is, and you are not. Best Line Ever.

In exploring my own prosopagnosia, I have realised that the way we perceive the world around us is extremely subjective and personal. When I compare notes with people who have dyslexia for example, I hear them talking about written words the way I talk about faces.

When they see printed text on a shop window or a street sign, they don't see the text, they see the shapes. Once they recognise those shapes as text, they can consciously make a decision to attempt to read it. For my part, I cant imagine seeing text and not reading it. Where they see shapes, I see language.

When it comes to faces, I see shapes, while you see people.

We can never truly know what another person sees when they look at the world, but I feel sure that it's nothing the rest of us would recognise. People with synesthesia, for example, can hear colours, and, growing up, probably assumed that the rest of us do as well.

The only thing we have in common is the fact that we have almost nothing in common. Thats why everyone reacts differently, and its one of the reasons why so many people hate each other so much. I really wish more of us would realise that; it would solve so many problems in this world.

For my part, I rather like the fact that I'm seeing things the way you don't (or vice versa). It constantly reminds me that everyone sees something different when they look at the same things. That's what gives the world its diversity.

Sadly, some people are frightened by diversity. I will never understand that. It's as plain to me as the face on your nose.

If you think you might have prosopagnosia, my best advice is to talk about it with your family and close friends. Compare notes. Let them know what youre dealing with. It really helps.

There are various facial recognition tests that are freely available online. I recommend these two:

http://www.faceblind.org/facetests/ff/ff_intro.php and http://facememory.psy.uwa.edu.au/

There are also many chat rooms, forums and Facebook groups devoted to prosopagnosia, including this Yahoo group:

https://groups.yahoo.com/neo/groups/faceblind/info

And finally, here is the NHS information page about prosopagnosia:

http://www.nhs.uk/Conditions/prosopagnosia/Pages/Introduction.aspx

Thanks for reading.

Read this article:
Geeks Vs Loneliness: face-blindness - Den of Geek UK

Read More...

Is Puma Biotechnology, Inc. (PBYI) a good buy? – TopChronicle

May 26th, 2017 2:41 pm

Share Price and 1 Year Extreme Prices Analysis

The share of Puma Biotechnology, Inc. (PBYI) currently has a value of $78.05 while the companys 52 week low is at $27.64, the shares dropped to the 52 week low on 06/27/16. While the companys share hit the 52 week high on 05/25/17 stationing the value of $75.10.

The difference of 52 week low value as well as 52 week high value and the current price of the stock suggests the next move of the shares. If the share price is currently hovering near the 52 week low and the value is achieved in the current past then it can suggest that the price of the shares is likely to go up.

Share Volume Analysis

The volume of the particular stock is the shares bought and sold in a single trading day. The average volume of a stock suggests the liquidity of a particular company. If the average volume is low then the liquidity is low which means it is hard to buy or sell the stock as there are fewer buyers or sellers of the stock.

Currently the shares of Puma Biotechnology, Inc. (PBYI) has the trading volume of 5.7 Million shares with the average trading volume of 5180 shares.

Price to Earnings Ratio

P/E of the company is not reported.

Earnings per Share EPS

Yet another important factor while evaluating a good buy/sell decision for Puma Biotechnology, Inc. (PBYI) is its Earnings per Share or EPS. EPS breaks down the profitability of the company on a single share basis.

Currently, EPS of Puma Biotechnology, Inc. (PBYI) is -1.97 while the analysts predicted the EPS of the stock to be -1.98 suggesting the company fell short of the analysts expectations.

Market Capitalization Analysis

Market Capitalization can be thought of as the overall price to buy the company. Market Capitalization if basically the market value of the companys shares outstanding. Market Cap is also the figure use to determine companys size, as opposed to using sales or total asset figures.

Puma Biotechnology, Inc. (PBYI) has a market capitalization of 2.89 Billion which suggests the company is a huge company further suggesting that the shares of Puma Biotechnology, Inc. (PBYI) are stable and safe compared to the lower market capitalization companies.

See original here:
Is Puma Biotechnology, Inc. (PBYI) a good buy? - TopChronicle

Read More...

The Bears And Bulls Square Off On Puma Biotechnology, Inc. (PBYI) – NY Stock News

May 26th, 2017 2:41 pm

NY Stock News
The Bears And Bulls Square Off On Puma Biotechnology, Inc. (PBYI)
NY Stock News
Puma Biotechnology, Inc. (PBYI) has presented a rich pool of technical data in recent sessions. These are the trends we've been tracking and how we feel they should be played in the current environment. Successful trading professionals know that in ...

and more »

More:
The Bears And Bulls Square Off On Puma Biotechnology, Inc. (PBYI) - NY Stock News

Read More...

Older adults might be able to stave off arthritis knee pain with fiber – Reuters

May 26th, 2017 2:41 pm

Older people who eat the most fiber are at lower risk of developing knee pain and stiffness due to osteoarthritis (OA), new research shows.

Diets rich in fiber from plant-based foods have clear health benefits, such as lower cholesterol, better-controlled blood sugar, and a healthier weight, but most people in the U.S. dont eat enough fiber, lead author Dr. Zhaoli Dai of Tufts University in Boston told Reuters Health.

The current average fiber intake among U.S. adults is about 15 grams, she noted. This is far below the recommended level, which is 22.4 grams for women and 28 grams per day for men 51 years and above, Dai said.

OA, which occurs when wear and tear on the joints degrades cartilage and leads to bone abnormalities, is extremely common in people 60 and older. It can be painful, and is also a leading cause of disability. There is no treatment for OA, aside from joint replacement, and therapies to address symptoms, such as anti-inflammatories for pain and swelling.

Given that dietary fiber is known to help prevent obesity and reduce inflammation, both of which are associated with arthritis, Dais team looked at diet and arthritis risk over time in two study groups. In the Osteoarthritis Initiative, which included 4,796 men and women with OA or at risk for OA, people who consumed the most dietary fiber at the start of the study were 30 percent less likely than those who ate the least fiber to develop knee pain, stiffness or swelling due to OA, or to worsening of OA, during four years of follow-up.

In the Framingham Offspring Study, which included 1,268 adults in their early 50s, on average, the top quarter of fiber consumers had a 61 percent lower risk of knee OA symptoms nine years later than the bottom quarter.

There are many mechanisms through which increased fiber intake could help ease knee arthritis symptoms, Dai said, for example by reducing inflammation and helping people to maintain a healthy weight. Fiber can also act as a pre-biotic, she added, meaning that it can help fuel the growth of beneficial microbes in the gut, which in turn also reduces inflammation.

This is the first study to show that consuming more dietary fiber is related to lower risk of painful knee osteoarthritis, Dai said. Changing diets by increasing intake of dietary fiber seems to be one of the most economic ways to reduce the risk of knee osteoarthritis.

Older adults, especially those who are overweight or obese, should consider increasing their fiber intake, she added.

SOURCE: bit.ly/2rVN8xU Annals of Rheumatic Diseases, May 4, 2017.

NEWTON, Mass. Former U.S. Army Specialist Tara Barney will never forget the 2013 night when a fellow soldier cried as he described holding a dying friend in his arms, a wartime memory he had not shared with anyone.

A moderate-intensity walking regimen may reduce symptoms of mild cognitive impairment that are linked to poor blood vessel health in the brain, a small study suggests.

LONDON The number of new drugs approved for sale in United States and Europe has bounced back this year, suggesting a marked slowdown in 2016 was an aberration rather than a sign of flagging research and development productivity.

Read the original here:
Older adults might be able to stave off arthritis knee pain with fiber - Reuters

Read More...

Arthritis in your hands? This new invention could change your life – Express.co.uk

May 26th, 2017 2:41 pm

GETTY

Arthritis can affect multiple parts of the body, including the fingers, hands and wrists.

This can cause trouble holding items, meaning cooking can become a challenge.

However, a university student has created a saucepan that can help sufferers of the condition retain their independence.

Emma Bucknell, who is studying for a BA (Hons) in Product Design at Nottingham Trent University, has designed it to make cooking more comfortable.

GETTY

It has a plastic handle on one side so users can slide their hand through it, meaning the saucepan can be lifted using the strength in the arm as opposed to the hand.

It has a plastic handle on one side so users can slide their hand through it, meaning the saucepan can be lifted using the strength in the arm as opposed to the hand.

The design does away with a traditionally straight saucepan handle, and instead aims to reduce weight and pressure that is placed on peoples fingers and hands.

Bucknell said: I know from my grandparents that arthritis is a painful and uncomfortable condition. My nan struggles with lifting saucepans so I took the opportunity to find a solution to help them.

During research she discovered that long, thin handles can prove a problem for arthritic people, because the hand is forced to perform an unnatural grip while holding on to them.

Getty

1 of 12

GETTY

She added: I can see that arthritis does not just affect a person with its painful symptoms, it affects their whole life. What many people would see as a simple task, can become difficult and sometimes impossible for those with the condition.

This can destroy independence; the one thing elderly and retired people desire to keep.

The aluminium saucepan is light to hold, and its handle can fit a range of different hand sizes.

It will go on display at the universitys 2017 Degree Show from 3 to 10 June at the City Campus.

GETTY

James Dale, principal lecturer in Product Design at Nottingham Trent University, said: Emma has seen first-hand how difficult it can be for people with arthritis to carry out tasks such as cooking and she has used this experience to create a product that could improve peoples confidence and independence.

The saucepan has the potential to go beyond the elderly market and reach others who have the same condition.

According to Arthritis Care, approximately 10 million people suffer from arthritis in the UK.

Both osteoarthritis and rheumatoid arthritis can affect the joints in the hands.

View post:
Arthritis in your hands? This new invention could change your life - Express.co.uk

Read More...

Arthritis: Suffering from arthritis? Vitamin D supplements may help – Economic Times

May 26th, 2017 2:41 pm

SYDNEY: Vitamin D supplements, combined with good sleeping habits, could help manage pain-related conditions including fibromyalgia, arthritis, menstrual cramps and chronic back pain, says a study.

The findings, published in the Journal of Endocrinology, suggest that vitamin D supplements combined with good sleep quality could increase the effectiveness of pain management treatments.

Previously published studies have shown that vitamin D can affect the body's inflammatory response, which also alters pain sensation.

This simple approach, if effective, could reduce the burden on health services and improve the lives of patients, the researchers said.

"The research is very exciting and novel. We are unravelling the possible mechanisms of how vitamin D is involved in many complex processes, including what this review shows -- that a good night's sleep and normal levels of vitamin D could be an effective way to manage pain," said Sof Andrikopoulos, Assistant Professor at University of Melbourne in Australia.

For the study, the team conducted reviews of the most relevant studies that have examined the role of vitamin D in pain-related conditions or sleep disturbances.

The results indicate that vitamin D levels may have an important role in the relationship between pain and sleep.

"It is necessary to understand the possible mechanisms involved in this relationship, including immunological and neurobiological pathways related to inter-relationship among sleep, vitamin D and pain," added Monica Levy Andersen from Universidade Federal de Sao Paulo in Brazil.

Continue reading here:
Arthritis: Suffering from arthritis? Vitamin D supplements may help - Economic Times

Read More...

How to protect yourself against vision loss, a growing problem – Chicago Tribune

May 25th, 2017 11:52 pm

Ask Americans to name the ailment they fear most, and blindness ranks at the top, along with Alzheimer's and cancer, according to a recent survey by the Wilmer Eye Institute at Johns Hopkins University. And yet each year, 50,000 Americans go blind, nearly half from eye diseases that are treatable or preventable.

What's worse, the number of Americans who are either blind or visually impaired is expected to double by 2050, most of it driven by an aging population and the growing number of people with chronic conditions that can cause vision loss, such as diabetes, says James Jorkasky, executive director of the National Alliance for Eye and Vision Research.

The challenge for vision experts is to make Americans aware of the things they can do to protect their eyesight, including getting a regular eye exam. Only half of the estimated 61 million Americans at high risk of losing their eyesight had an eye exam in the past 12 months partly due to a lack of insurance coverage for preventive eye care and glasses, noted a National Academies of Sciences, Engineering and Medicine report last fall, but also because many eye diseases don't show symptoms in the early stages, so people don't realize they have a problem.

Doctors, too, may need to step up their game. A new study in the journal JAMA Ophthalmology found that in one of four cases, trained eye professionals missed the early, more treatable signs of age-related macular degeneration (AMD) an irreversible loss of vision that affects 14 million Americans.

But there is some good news for those already diagnosed with eye disease, including new treatments and cutting edge research that could bring hope to millions in the near future. There are also simple changes everyone can do to greatly reduce their risk of eye disease. Here's what you need to know:

Cutting edge technologies

Glaucoma is caused by a buildup of damaging pressure within the eye and requires a daily dose of medicated eye drops to hold the disease at bay. Unfortunately, getting patients to follow that regimen daily for years is difficult, says Dr. Andrew Iwach, board chairman for the Glaucoma Research Foundation. Instead, clinical trials have started testing a thin polymer ring to be worn in the eye that would slowly release medication throughout the day. "It's like drip irrigation, rather than flooding the eye," Iwach says.

Using stem cells to regenerate healthy cells in disease-damaged eyes is the holy grail for researchers. This is especially true for incurable conditions that damage the retina, the layer of light-sensitive cells at the back of the eye.

Earlier this year, a Japanese man became the first person to receive retinal stem cells created from donated skin cells to stop his macular degeneration from getting worse.

And scientists at the Jules Stein Eye Institute at the University of California at Los Angeles report promising results from transplanting stem cells from embryonic cells into patients who had been blind for decades from AMD and another disease. A study in 2014 reported that 10 of the 18 patients who received the cells experienced significantly improved vision.

The Argus II, a bionic retina approved by the Food and Drug Administration, is now being used by more than 100 people with retinitis pigmentosa and other related conditions. It also recently was implanted in the first person with macular degeneration.

This "bionic eye" uses a tiny camera attached to glasses that sends visual data to a microchip implanted in the eye, which then sends light signals to the brain. So far, the vision it provides is rudimentary, but patients say even some vision can greatly improve the quality of life for a blind person.

Ways to help your eyes

To keep your eyes healthy, says the National Eye Institute, get a dilated eye exam to detect problems early; know your family history and whether you're at risk for eye disease; wear sunglasses to block out ultraviolet rays that can increase the risk of cataracts; and control your diabetes to prevent damage to the retina.

Here are five other surprising things that can help:

Adjust your yoga and sleep position: Those with glaucoma should avoid head-down positions in yoga (downward facing dog, for example), which can cause a dangerous rise in internal eye pressure, a study last year found. Other studies show that habitually sleeping on one side can cause greater pressure and worsening vision loss in the eye facing downward.

Got dry, irritated eyes? Add more fish to your diet. The omega-3 oils in fish not only can cut the risk of dry eyes, studies show, but omega-3 fish oil supplements may improve dry eye symptoms. A new study published in the journal Cornea found that taking a daily omega-3 supplement improved dry eye symptoms after six weeks.

Think of it as Vitamin See. A diet high in vitamin C oranges, red peppers, strawberries, broccoli may help curb cataracts by 33 percent. British researchers believe vitamin C helps prevent the clouding of the lens that causes cataracts, but their findings only pertain to vitamin C from food, not supplements.

Send your children outside. Adults aren't the only ones with dry eye woes. A new study finds the same problem among children ages 7 to 12 who spend more than three hours daily looking at a smartphone. Playing outside could help. Researchers at the University of Cambridge report that for every hour children play outside in natural light with far-away horizons, they reduce their risk of near-sightedness by 2 percent.

Exercise (and spinach) helps glaucoma. A brisk walk for 20 minutes four times a week can lower the pressure inside the eye, which helps protect the retina, according to the Glaucoma Research Foundation. Adding more dark, leafy greens spinach, kale to your diet could help too. A recent study found that those who ate the most greens were 21 percent less likely to develop glaucoma.

Candy Sagon is a freelance writer.

RELATED STORIES:

Untreated vision problems plague U.S. preschoolers

Here's how often you should look away from your computer screen

Read the rest here:
How to protect yourself against vision loss, a growing problem - Chicago Tribune

Read More...

Page 1,021«..1020..1,0201,0211,0221,023..1,0301,040..»


2025 © StemCell Therapy is proudly powered by WordPress
Entries (RSS) Comments (RSS) | Violinesth by Patrick